Abnormal hemoglobin A1c is associated with an increased rate of target vessel revascularization in nondiabetic patients undergoing percutaneous coronary revascularization

✍ Scribed by Roberto A. Corpus Jr.; Judith A. Boura; Steven C. Ajluni; William H. Devlin; Simon R. Dixon; Gerald C. Timmis; William W. O'Neill

• Book ID: 119543760
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 145 KB
• Volume: 39
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(02)80207-8